AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

GSK PLC closed 24.32% short of its 52-week high of £18.24, which the company achieved on May 16th.

CORE EARNINGS PER SHARE FORECAST: Fourth-quarter core earnings per share is expected to fall to 20.6 pounds from 28.9 pounds the year earlier, according to Visible Alpha. Shares in GSK are 3.6% up ...

On Monday, GSK plc (GSK) stock saw a decline, ending the day at $34.9 which represents a decrease of $-0.37 or -1.05% from the prior close of $35.27. The stock opened at $34.87 and touched a low of ...

Bearish flow noted in GSK (GSK) Pharma with 1,131 puts trading, or 2x expected. Most active are Mar-25 33 puts and Jan-26 35 puts, with total volume in those strikes near 730 contracts. The Put/Call ...

Trump's tariffs could derail Europe's 2025 growth, say top Wall Street analysts. Goldman Sachs sees eurozone GDP at 0.7%, ...

A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a ...

A Westchester woman is raising awareness about the challenges that people with gynecologic cancers face. Jennifer Garam said ...

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

The global vulvodynia treatment market is poised for significant growth, with sales expected to rise from USD 6.7 billion in 2025 to USD 12.4 billion by 2035, reflecting a CAGR of 6.3% over the ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use of depemokimab in two indications. The submitted indicati ...